GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $47,718,000 | -42.9% | 220,000 | -69.6% | 0.09% | -45.6% |
| Q4 2020 | $83,524,000 | -0.4% | 723,715 | -16.0% | 0.17% | -13.2% |
| Q3 2020 | $83,891,000 | -17.0% | 861,744 | +4.7% | 0.20% | -21.2% |
| Q2 2020 | $101,048,000 | +53.2% | 823,400 | +9.3% | 0.25% | +28.9% |
| Q1 2020 | $65,978,000 | +94.5% | 753,432 | +132.3% | 0.19% | +155.3% |
| Q4 2019 | $33,919,000 | +2.8% | 324,400 | +13.1% | 0.08% | -6.2% |
| Q3 2019 | $32,989,000 | -37.3% | 286,790 | -6.0% | 0.08% | -36.7% |
| Q2 2019 | $52,613,000 | -25.3% | 305,200 | -26.9% | 0.13% | -26.4% |
| Q1 2019 | $70,420,000 | +113.7% | 417,750 | +23.5% | 0.17% | +93.3% |
| Q4 2018 | $32,955,000 | -25.9% | 338,383 | +31.5% | 0.09% | -13.5% |
| Q3 2018 | $44,446,000 | +41.4% | 257,300 | +14.2% | 0.10% | +13.0% |
| Q2 2018 | $31,438,000 | -6.4% | 225,300 | -24.4% | 0.09% | -6.1% |
| Q1 2018 | $33,598,000 | -14.7% | 298,200 | 0.0% | 0.10% | -11.7% |
| Q4 2017 | $39,365,000 | +53.9% | 298,200 | +18.3% | 0.11% | +52.1% |
| Q3 2017 | $25,586,000 | -1.8% | 252,100 | -3.0% | 0.07% | -2.7% |
| Q2 2017 | $26,065,000 | -17.1% | 260,000 | 0.0% | 0.08% | -16.7% |
| Q1 2017 | $31,444,000 | +16.5% | 260,000 | +7.6% | 0.09% | +11.1% |
| Q4 2016 | $26,999,000 | -29.3% | 241,600 | -16.0% | 0.08% | -26.4% |
| Q3 2016 | $38,184,000 | -16.8% | 287,680 | -42.6% | 0.11% | -17.9% |
| Q2 2016 | $45,877,000 | +26.9% | 501,000 | 0.0% | 0.13% | +19.6% |
| Q1 2016 | $36,147,000 | +51.9% | 501,000 | +46.2% | 0.11% | +49.3% |
| Q4 2015 | $23,797,000 | -55.9% | 342,700 | -41.9% | 0.08% | -57.1% |
| Q3 2015 | $53,927,000 | -48.7% | 590,200 | -31.0% | 0.18% | -44.4% |
| Q2 2015 | $105,053,000 | +128.6% | 855,200 | +69.6% | 0.32% | +125.0% |
| Q1 2015 | $45,948,000 | +24.2% | 504,200 | -7.8% | 0.14% | +22.8% |
| Q4 2014 | $37,007,000 | -22.1% | 546,800 | -7.0% | 0.11% | -25.5% |
| Q3 2014 | $47,524,000 | +10.3% | 587,808 | +46.4% | 0.15% | +13.3% |
| Q2 2014 | $43,078,000 | +121.3% | 401,514 | +22.5% | 0.14% | +107.7% |
| Q1 2014 | $19,463,000 | – | 327,814 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |